27/11/2012 - General information
Two studies led by researchers from the neuroimaging research group at IMIM led by Òscar Vilarroya, and which also involved researchers from UAB and the Hospital de la Vall d’Hebron, have been cited in the “Consensus Report of the APA Work Group” as international reference works in the area of attention deficit and hyperactivity disorder (ADHD), conferring upon these researchers the status of world leaders in this field.
Més informació "IMIM researchers world leaders in neuroimaging and ADHD research"
12/09/2012 - General information
The project- based on a collaboration agreement between the Barcelona Science Park (PCB) and the companies SOM Biotech and Metasbio– will enable the discovery of new therapeutic applications of previously existing drugs (repurposing), especially in areas of great medical need and market potential, such as the central nervous system, oncology and orphan diseases.
23/07/2012 - General information
From the 27th of July until the 12th of August the London 2012 Olympics will be taking place. Once again, and thanks to an agreement between King’s College in London and the IMIM Foundation, as of the 23rd of July a group of technicians from the IMIM Bioanalysis and Analysis Services research group will join the Official Antidoping Laboratory of the London 2012 Olympics.
Més informació "The IMIM Antidoping Control Lab in London 2012"
21/06/2012 - General information
"Connect, partner and innovate". This is the slogan for the twentieth edition of the BIO International Convention, held 18 to 21 June 2012 in the city of Boston (Massachusetts, United States). BIO is the most important international business meeting in the biotechnology arena. This year, it will bring together more than 15,000 delegates from 65 countries, more than 900 exhibitors and 1,800 companies. In addition to the exhibition area, it also features a Business Forum for partnering meetings, which in 2011 generated more than 21,000 one-to-one meetings.
Més informació "GRIB participated at BIO Boston 2012, the top biotechnology convention in the world"
21/05/2012 - General information
After one week of intensive training, the closing event of the INBIOMEDvision Training Challenge successfully took place in Barcelona. This training gathered together two teams of 5 PhD students with different nationalities and scientific backgrounds (chemists, medical doctors, informatics, mathematics, biologists etc.) to work on two case studies related with health sciences during one week at the Monastery of Les Avellanes (Lleida, Spain).
15/03/2012 - General information
The European project EU contributions to the World Mental Health Survey Initiative (EU-WMH, 2009-2011) coordinated by Jordi Alonso, started with the goal of estimating the frequency, distribution and consequences of mental disorders in Europe, while increasing awareness and strengthening existing public initiatives on mental health in the fields of research and politics.
Més informació "Mental health in Europe: results of the European EU-WMH project"
8/03/2012 - General information
Jordi Segura, Director of the Laboratory for Anti-Doping Control of the Hospital del Mar Research Institute (IMIM), was recently appointed President of the World Association of Anti-Doping Scientists (WAADS) for a two-year period and member of the Scientific Committee of the Catalan Ministry of Sport.
Més informació "Scientific scope of the IMIM’s anti-doping laboratory"
29/02/2012 - General information
The prototype of a knowledge tool developed by the Open PHACTS Consortium has proven useful by identifying relevant information in a matter of seconds, when a traditional search could take days. It will provide information on small molecules, their pharmacological profile, pharmacokinetics, etc. from multiple sources available on the Internet.
18/11/2011 - General information
This November IMIM (Research Institute Hospital del Mar) celebrates its three years of history on twitter. This initiative began as a pioneer experience in the field of research to disseminate to the general public the news of the institution, the calendar of courses and conferences, the Inforecerca and everything that is published in the science bloc IMIMA'T. The twitter of the IMIM has been consolidated with success and currently has over 400 followers.
28/01/2011 - General information
Laura López, Cristian Obiol-Pardo and Jana Selent, members of the Computer Aided Drug Design (CADD) group of the Biomedical IT Research Group (GRIB, of the UPF-IMIM) have won first prize for the best prediction of the ligands established by the GPCR protein, a molecule which intervenes in many cell processes and interacts with half of all known drugs.
Més informació "GRIB Members Win an International Competition"
Servei de Comunicació:
Marta Calsina Freixas(ELIMINAR)
Tel:
(+34) 93 316 06 80
Doctor Aiguader, 88
08226 Barcelona
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact
